(Q71691168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

20 October 2019

main subject

1 reference

2

Toubi E

1 reference

20 October 2019

Zuckerman E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Shiran A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Sabo E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Shmuel Z

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Golan TD

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Abinader E

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Yeshurun D

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 October 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

381-386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Antiphospholipid antibodies detected as anticephalin and anticardiolipin antibodies in patients with acute myocardial infarction: immunological response to myocardial necrosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Serologic response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Anticardiolipin antibodies are no marker for survived myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Antiphospholipid antibodies in patients with previous myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Anticardiolipin antibodies in ischaemic heart disease: marker or myth?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Importance of serum anticardiolipin antibody levels in coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

The presence of antiphospholipid antibodies in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Anticardiolipin antibodies in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900226-4

10.1016/S0002-9343(96)00226-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8873508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference